In this overview, we will present current information on known mutations in the TLR4 signaling pathway that have been associated with increased susceptibility to disease. To date, mutations in the extracellular domain of TLR4 itself, IRAK-4, NEMO (IKKγ), and IκBα have been identified and profoundly affect the host response to infection.
Sabroe I., Read RC, Whyte MK, Dockrell DH, Vogel SN, Dower SKToll-like receptors in health and disease: complex questions remain . J Immunol2003; 171: 1630—1635.
5.
Kurt-Jones EA , Popova L., Kwinn L. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol2000; 1: 398—401.
6.
Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen kS, Equis O. et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol2002; 168: 1435—1440.
7.
Malley R., Henneke P., Morse SC et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA2003; 100: 1966—1971.
8.
Perera P-Y., Mayadas TN, Takeuchi O. et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression . J Immunol2001; 166: 574—581.
9.
Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K., Nishijima M.Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide mimetic signal transduction by Taxol. J Endotoxin Res2001; 7: 232—236.
Toshchakov V., Jones BW, Perera PY et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol2002; 3: 392—398.
12.
Gao JJ, Diesl V., Wittmann T. et al. Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages. J Endotoxin Res2003; 9: 237—243.
13.
Bjorkbacka H., Fitzgerald KA, Huet F. et al. The induction of macrophage gene expression by LPS predominantly utilizes MyD88-independent signaling cascades. Physiol Genomics2004 ; 19: 319—330.
14.
Smirnova I. , Poltorak A., Chan EK, McBride C., Beutler B.Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol2000; 1: RESEARCH002.
15.
Arbour NC, Lorenz E., Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet2000; 25: 187—191.
16.
Raby BA, Klimecki WT, Laprise C. et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med2002; 166: 1449—1456.
17.
Newport MJ, Allen A., Awomoyi AA et al. The Toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia . Tuberculosis (Edinb) 2004; 84: 347—352.
18.
Lorenz E., Hallman M., Marttila R., Haataja R., Schwartz DAAssociation between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res2002; 52: 373—376.
19.
Tal G., Mandelberg A., Dalal I. et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis2004; 189: 2057—2063.
20.
Hartel CH, Finas D., Ahrens P. et al. Genetic Factors in Neonatology Study Group. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod2004; 10: 911—915.
21.
Lorenz E., Schwartz DA, Martin PJ et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant2001; 7: 384—387.
22.
Lorenz E., Mira JP, Frees KL, Schwartz DARelevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med2002; 162: 1028—1032.
23.
Agnese DM, Calvano JE, Hahm SJ et al. HumanToll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis2002; 186: 1522—1525.
24.
Morre SA, Murillo LS, Spaargaren J., Fennema HS, Pena ASRole of the Toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis2002; 186: 1377—1379.
25.
Morre SA, Murillo LS, Bruggeman CA, Pena ASThe role that the functional Asp299Gly polymorphism in the Toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatisassociated tubal infertility . J Infect Dis2003; 187: 341—342.
26.
Genc MR, Vardhana S., Delaney ML, Onderdonk A., Tuomala R., Norwitz E., Witkin SS; MAP StudyGroup. Relationship between a Toll-like receptor-4 gene polymorphism, bacterial vaginosisrelated flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol2004 ; 116: 152—156.
27.
Read RC, Pullin J., Gregory S. et al. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis2001; 184: 640—642.
28.
Franchimont D., Vermeire S., El Housni H. et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis . Gut2004; 53: 987—992.
29.
Ohkusa T., Nomura T., Sato N.The role of bacterial infection in the pathogenesis of inflammatory bowel disease. Intern Med2004; 43: 534—539.
30.
Kiechl S., Lorenz E., Reindl M. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med2002; 347: 185—192.
31.
Edfeldt K., Bennet AM, Eriksson P. et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J2004; 25: 1447—1453.
32.
Radstake TR , Franke B., Hanssen S. et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Ann Rheum Dis2004; 63: 696—702.
33.
Vogel SN, Bhat N., Malo D., Qureshi STGenetic control of endotoxin responsiveness. In: Brade H, Opal SM, Vogel SN, Morrison DC. (eds) Endotoxin in Health and Disease. New York : Marcel Dekker, 1999; 735—750.
34.
Michelsen KS , Wong MH, Shah PK et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA2004; 101: 10679—10684.
35.
Suzuki N., Suzuki S., Duncan GS et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature2002; 416: 750—756.
36.
Picard C., Puel A., Bonnet M. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency . Science2003; 299: 2076—2079.
37.
Medvedev AE , Lentschat A., Kuhns DB et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med2003; 198: 521—531.
38.
Currie AJ, Davidson DJ, Reid GS et al. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. J Pediatr2004; 144: 512—518.
39.
Kuhns DB, Long Priel DA, Gallin JIEndotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol1997; 158: 3959—3964.
40.
Puel A., Yang K., Ku C-L. et al. Heritable defects of the human TLR signaling pathways. J Endotoxin Res2005; 220—224.
41.
Jacobs H., Bross L.Towards an understanding of somatic hypermutation. Curr Opin Immunol2001; 13: 208—218.
Puel A., Picard C., Ku CL, Smahi A., Cassanova JLInherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol2004; 16: 34—41.
44.
Courtois G. , Smahi A., Reichenbach J. et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest2003 ; 112: 1108—1115.
45.
Medvedev AE , Thomas K., Awomoyi A., Kuhns DB, Gallin JI, Li X., Vogel SNCutting edge: expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters IRAK-4 interaction with components of the IL-1 receptor complex. J Immunol2005; 174: 6587—6591.
